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²  Different types of PAR1 stimulation promotes differences in 
microglia activation. 
²  Direct activation of PAR1 on oligodendrocyte progenitor cell  
cultures does not affect proliferation. 
²  Activating PAR1 on all glial cells at the same time in mixed glial 
cultures also does not change OPC proliferation.  
²  Factors from PAR1 activated microglia that are not in contact 
with OPCs increase OPC proliferation, and survival.  
²  PAR1 may be playing a role in promoting OPC proliferation 
through activated microglia.  
²  This makes PAR1 a potential target for the development of 
treatments for tissue repair after spinal cord injury. 
²  Follow up study: Analyze the phenotypes of PAR1 agonist vs. 
thrombin activated microglia in culture and in vivo.  
 
²  Protease Activated Receptor 1 (PAR1) is a G-protein 
coupled receptor present on many central nervous 
system cell types. 
²  When cleaved by serine proteases, PAR1 can initiate 
many different signaling cascades based on the activator.  
 
²  The activators of PAR1 are found in blood, and get into 
the spinal cord after injury.  
²  Microinjection of a synthetic PAR1 agonist into normal rat 
spinal cord stimulated marked oligodendrocyte 
progenitor cell (OPC) proliferation, while the 
endogenous activator thrombin did not. 
²  OPCs are important for repair after spinal cord injury. 
 
²  Our goal is to determine the mechanism of PAR1-
mediated OPC proliferation: Is it direct or indirect?  
²  If it is indirect, which cell/cells are responsible for 
secreting factors that stimulate OPC proliferation?   
A-C) PAR1 Agonist and thrombin stimulated different patterns of microglia 
activation within the microinjection area (boxes) centered at the base of the 
needle track.   
A’-C’) Arrows identify examples of CD11b+ cells (a marker for microglia). 
Microglia with activated morphology (rounder, less processes) can be seen in 
PAR1 Agonist and Thrombin.  
D.) CD11b area was quantified in microinjection areas (boxes in A-C). 
Thrombin stimulated increased accumulation of microglia. 
Fig.1: Different Modes of PAR1 Activation Affect 
Microglia Morphology and Accumulation 
Fig.2: Direct Activation of PAR1 in Cultured 
Oligodendrocyte Progenitor Cells Does not Affect 
Their Proliferation 
Fig.3: PAR1 Activated Microglia Promote Survival 
and Proliferation of OPC Cultures   
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A.) Immunoflourescence was used  to identify proliferating OPCs. Example of a 
non-proliferating OPC vs. a proliferating OPC. Proliferating OPCs were 
identified by bright red BrdU+ nuclei surrounded by green speckled A2B5 
staining.  
 
B.) Activation of PAR1 directly on OPCs does not increase proliferation. 
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“Non-contact” co-cultures grown in transwell inserts, allowing for 
microglia secretions to indirectly affect OPCs. 
 
A.) PAR1 activated microglia in transwells increased OPC survival. 
Indicating a possible protective role for PAR1 activated microglia. 
 
B.) Thrombin activated microglia increased OPC proliferation. 
 
-  Vehicle: PBS (phosphate buffered 
saline) 
-  PAR1 Agonist (TFLLR): 
Synthesized peptide that selectively 
activates protease activated 
receptor 1 
 
-  Thrombin: Serine protease, found 
in blood. Endogenous activator of 
PAR1, but can activate the other 
PARs as well. 1000X more potent 
than TFLLR 
-  Tissue perfused with 
4% Paraformaldehyde 
-  Tissue is processed 
for histology 
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Fig.4: PAR1 Activation in Mixed Cultures Does 
not Increase OPC Proliferation 
PAR1 activation in mixed cultures 
(OPCs, microglia, and astrocytes all 
together) did not show a robust effect in 
OPC proliferation. 
